For example, lack of feeding assistance at mealtimes may hinder intake of the 1 hospital meals and patients are often unwilling or unable to consume ONS. As a 2 result, innovative strategies to improve the delivery and consumption of ONS as 3 well as reduce wastage and costs have evolved. 4 One innovative strategy is the concept of prescribing a calorically dense ONS 5 on the medication chart in small volumes frequently throughout the day 16.
6
Commonly known as either 'Med Pass' or Nutrition as Medication (or NAM) this 7 program's efficacy in improving energy and protein intake is well described 17-19. 8 Despite clear evidence of benefits associated with NAM and the existence of 9 routine clinical guidelines to implement NAM 20 , we hypothesise that the deficit in Details about the study aims and objectives were discussed with the relevant 8 Medical Stream Service Directors and permission to undertake the research 9 also sought from each ward Nurse Unit Manager. Usual ward practice was 10 followed: the Dietitian discussed the NAM prescription with the patient; NAM 11 was documented on the medication chart by the Doctor; and Nursing staff 12 administered the NAM.
13
Data collection included demographic information, anthropometry, nutritional 14 status score (20) (21) and length of stay (LOS). Medication charts of all study 15 patients were reviewed retrospectively to obtain information on the type, timing, 16 duration and volume of nutritional supplement prescribed. The number of doses 17 of NAM received or refused by patients was also obtained from the medication 18 chart in addition to the reasons documented by nursing staff for non receival.
19
The same study patients also consented to a minimum of three observations of 20 the NAM delivery process to determine if there were any additional 21 environmental factors influencing delivery and consumption of NAM. Permission 22 to observe nursing staff on the study wards was obtained from each ward Nurse 23 Unit Manager. Details regarding the study aims were provided by the Nurse Unit Manager to nursing staff at handover and the research assistant was introduced 1 to nursing staff at the commencement of the data collection period.
2
Observations using a standardised data collection sheet were carried out 3 between the hours of 0800 and 1730 hours by a single investigator (the study 4 research assistant) and were timed to coincide with the various NAM 5 prescription times charted for each patient. Observations were not covert and 6 patients and nursing staff were aware of the observer's presence on the ward. 14 These tests were used to investigate differences between wards for relevant 15 variables. A p value of <0.05 was considered significant for all analyses. Ethics line strategy to improve protein and kilojoule intake [26] [27] . Possible reasons for 1 the high level of compliance include a reduced likelihood of inducing 'taste 2 fatigue', as well as minimal interference with a patient's appetite at subsequent 3 mealtimes due to the 'user friendly' small volumes dispensed 28 . Patients may 4 also be more likely to perceive NAM as an important treatment to aid recovery 5 because it is dispensed in a similar manner to other medications. 6 The second significant finding is the identification of a gap in our institution 7 between 'best practice' and 'real life practice'. Observations indicated that one 8 in three doses were not received by the patient. Furthermore, geriatric patients 9 in this study, were observed to only receive one in every two doses of NAM Commission suggests that if health services choose to use the NIMC then risk 2 assessments should be undertaken and appropriate policies, procedures and 3 education provided to staff. Our study identified considerable scope, more 4 broadly, for improvement with medication reconciliation practices in a tertiary 5 hospital setting in regional New South Wales, and attention to this matter could 6 constitute a useful multidisciplinary quality improvement activity. This may also 7 lead to improvements in NAM delivery and improved clinical outcomes for 8 patients.
9
The authors acknowledge there are several important limitations to this study.
10
These include a lack of generalisability of the findings, as participants were Mean number of medications charted 13.1 ± 3.4 6.9 ± 6.0 10.3 ± 1.3 0.02* 
